insights_auto
Why is INCY down 3,47%?
Dive Deeperchevron_right
INCY:NASDAQ
Incyte Corp
117,14 $
arrow_downward
-3,47%(-4,21) 1D
117,44 $
arrow_upward
+0,26% (+0,30)todayPre-market
Closed: 1 қаз., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
120,47 $
High
121,22 $
Low
117,00 $
Mkt. cap
23,74 млрд
Avg. vol.
1,42 млн
Volume
339,00
P/E ratio
14,93
52-wk high
132,58 $
52-wk low
82,82 $
EPS
7,85 $
Beta
0,77
Shares outstanding
202,70 млн
No. of employees
3 мың
Open
120,47 $
High
121,22 $
Low
117,00 $
Mkt. cap
23,74 млрд
Avg. vol.
1,42 млн
Volume
339,00
P/E ratio
14,93
52-wk high
132,58 $
52-wk low
82,82 $
EPS
7,85 $
Beta
0,77
Shares outstanding
202,70 млн
No. of employees
3 мың
News stories
From web sources and news partners
Benzinga
·
11 сағат бұрын
If You Invested $1000 In Incyte Stock 20 Years Ago, You Would Have This Much Today
Yahoo Finance
·
13 сағат бұрын
Q2 Earnings Roundup: Incyte (NASDAQ:INCY) And The Rest Of The Biotechnology Segment
GuruFocus
·
19 сағат бұрын
INCY Maintained by Wells Fargo -- Price Target Raised to $128
AD HOC NEWS
·
1 күн бұрын
Incyte presents EADV data for Incyte stock
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2,84 мың
Founded2002
HeadquartersWilmington, Делавэр, Америка Құрама Штаттары
Sector-
Websiteincyte.com